{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:20:44Z","timestamp":1792120844360,"version":"4.4.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T00:00:00Z","timestamp":1355961600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0052208","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T17:06:15Z","timestamp":1356023175000},"page":"e52208","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients with Multiple Sclerosis"],"prefix":"10.1371","volume":"7","author":[{"given":"Thomas F.","family":"Benkert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena M.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Leich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Serfling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Buttmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Berberich-Siebelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,12,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","article-title":"Multiple sclerosis","volume":"359","author":"A Compston","year":"2002","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00019052-200106000-00006","article-title":"Immunological update on multiple sclerosis","volume":"14","author":"R Hohlfeld","year":"2001","journal-title":"Curr Opin Neurol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00415-008-6001-2","article-title":"Pathophysiology of multiple sclerosis","volume":"255","author":"T Korn","year":"2008","journal-title":"J Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1749-6632.1992.tb49149.x","article-title":"Tumor necrosis factor-alpha and interferon-gamma synthesis by cerebrospinal fluid-derived T cell clones in multiple sclerosis","volume":"650","author":"R Benvenuto","year":"1992","journal-title":"Ann N Y Acad Sci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/08916939309043888","article-title":"T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes","volume":"15","author":"RR Voskuhl","year":"1993","journal-title":"Autoimmunity"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"CL Langrish","year":"2005","journal-title":"J Exp Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ana.21748","article-title":"Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis","volume":"66","author":"H Kebir","year":"2009","journal-title":"Ann Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: bidirectional, allosteric signaling machines","volume":"110","author":"RO Hynes","year":"2002","journal-title":"Cell"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/nri1646","article-title":"Intracellular signalling controlling integrin activation in lymphocytes","volume":"5","author":"T Kinashi","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"E65","DOI":"10.1038\/ncb0402-e65","article-title":"Networks and crosstalk: integrin signalling spreads","volume":"4","author":"MA Schwartz","year":"2002","journal-title":"Nat Cell Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4615-2920-0_38","article-title":"Expression of endothelial cell activation antigens in microvessels from patients with multiple sclerosis","volume":"331","author":"P Dore-Duffy","year":"1993","journal-title":"Adv Exp Med Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ana.410350114","article-title":"Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis","volume":"35","year":"1994","journal-title":"Ann Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1084\/jem.177.1.57","article-title":"Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma","volume":"177","author":"JL Baron","year":"1993","journal-title":"J Exp Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/356063a0","article-title":"Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin","volume":"356","author":"TA Yednock","year":"1992","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nrd1752","article-title":"Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab","volume":"4","author":"L Steinman","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"CH Polman","year":"2006","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1586\/ern.10.38","article-title":"Treating multiple sclerosis with monoclonal antibodies: a 2010 update","volume":"10","author":"M Buttmann","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"366","author":"G Bloomgren","year":"2012","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/NEN.0b013e31825caf2c","article-title":"Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab","volume":"71","author":"BK Kleinschmidt-DeMasters","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneurol.2010.257","article-title":"Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy","volume":"68","author":"A Miravalle","year":"2011","journal-title":"Arch Neurol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1212\/WNL.0b013e31822e55e7","article-title":"Immune reconstitution inflammatory syndrome in natalizumab-associated PML","volume":"77","author":"IL Tan","year":"2011","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases","volume":"9","author":"DB Clifford","year":"2010","journal-title":"Lancet Neurol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1212\/WNL.0b013e31821e7c8a","article-title":"Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis","volume":"76","author":"PW O\u2019Connor","year":"2011","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jns.2011.05.043","article-title":"Natalizumab and drug holiday in clinical practice: an observational study in very active relapsing remitting multiple sclerosis patients","volume":"308","author":"A Kerbrat","year":"2011","journal-title":"J Neurol Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1212\/01.wnl.0000265393.03231.e5","article-title":"Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients","volume":"70","author":"MM Vellinga","year":"2008","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ana.22163","article-title":"Natalizumab dosage suspension: are we helping or hurting?","volume":"68","author":"TW West","year":"2010","journal-title":"Ann Neurol"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Rigau V, Mania A, Befort P, Carlander B, Jonquet O, <etal>et al<\/etal>.. (2012) Lethal Multiple Sclerosis Relapse after Natalizumab Withdrawal. Neurology.","DOI":"10.1212\/WNL.0b013e318275979d"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1212\/WNL.0b013e3181a8266f","article-title":"Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells","volume":"72","author":"P Kivisakk","year":"2009","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/1352458510392263","article-title":"CD4+T-bet+, CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment","volume":"17","author":"G Frisullo","year":"2011","journal-title":"Mult Scler"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10875-011-9522-x","article-title":"Treatment with natalizumab in relapsing-remitting multiple sclerosis patients induces changes in inflammatory mechanism","volume":"31","author":"J Ramos-Cejudo","year":"2011","journal-title":"J Clin Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"CH Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood-2005-04-1660","article-title":"Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus","volume":"107","author":"O Beck","year":"2006","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/intimm\/dxm014","article-title":"Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production","volume":"19","author":"SE Allan","year":"2007","journal-title":"Int Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1074\/jbc.M111.321182","article-title":"Metalloproteinase-mediated Shedding of Integrin beta2 promotes macrophage efflux from inflammatory sites","volume":"287","author":"IG Gomez","year":"2012","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1182\/blood-2007-08-109249","article-title":"Alpha4beta1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B\/MMP-9 in chronic leukemic but not in normal B cells","volume":"112","author":"J Redondo-Munoz","year":"2008","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jneuroim.2010.07.012","article-title":"Natalizumab treatment reduces endothelial activity in MS patients","volume":"227","author":"A Millonig","year":"2010","journal-title":"J Neuroimmunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/ana.20859","article-title":"Natalizumab effects on immune cell responses in multiple sclerosis","volume":"59","author":"M Niino","year":"2006","journal-title":"Ann Neurol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00011-010-0177-5","article-title":"Anti-alpha4beta1 integrin antibody induces receptor internalization and does not impair the function of circulating neutrophilic leukocytes","volume":"59","author":"JC Fleming","year":"2010","journal-title":"Inflamm Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"11058","DOI":"10.1073\/pnas.0307927101","article-title":"VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses","volume":"101","author":"M Mittelbrunn","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.immuni.2008.04.019","article-title":"T cell costimulation via the integrin VLA-4 inhibits the actin-dependent centralization of signaling microclusters containing the adaptor SLP-76","volume":"28","author":"K Nguyen","year":"2008","journal-title":"Immunity"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jmb.2007.11.040","article-title":"Structural basis for the interaction between focal adhesion kinase and CD4","volume":"375","author":"ML Garron","year":"2008","journal-title":"J Mol Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"8113","DOI":"10.1128\/MCB.24.18.8113-8133.2004","article-title":"SRC-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signaling","volume":"24","author":"MA Westhoff","year":"2004","journal-title":"Mol Cell Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.humimm.2009.09.360","article-title":"Co-engagement of alpha(4)beta(1) integrin (VLA-4) and CD4 or CD8 is necessary to induce maximal Erk1\/2 phosphorylation and cytokine production in human T cells","volume":"71","author":"TK Kim","year":"2010","journal-title":"Hum Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nri2818","article-title":"NFAT, immunity and cancer: a transcription factor comes of age","volume":"10","author":"MR Muller","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"S Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2567.2008.02963.x","article-title":"Regulatory T cells fail to suppress CD4T+-bet+ T cells in relapsing multiple sclerosis patients","volume":"127","author":"G Frisullo","year":"2009","journal-title":"Immunology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1182\/blood-2007-09-112052","article-title":"Increased numbers of circulating hematopoietic stem\/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab","volume":"111","author":"H Bonig","year":"2008","journal-title":"Blood"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1517\/14712590903055011","article-title":"The role of natalizumab in hematopoietic stem cell mobilization","volume":"9","author":"F Neumann","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1001\/archneurol.2011.238","article-title":"Natalizumab and impedance of the homing of CD34+ hematopoietic progenitors","volume":"68","author":"C Saure","year":"2011","journal-title":"Arch Neurol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1468-1331.2009.02532.x","article-title":"The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers","volume":"16","author":"M Khademi","year":"2009","journal-title":"Eur J Neurol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1468-1331.2007.02037.x","article-title":"Induction of systemic TNFalpha in natalizumab-treated multiple sclerosis","volume":"15","author":"M Khademi","year":"2008","journal-title":"Eur J Neurol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jneuroim.2007.11.007","article-title":"Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients","volume":"194","author":"RL Lindberg","year":"2008","journal-title":"J Neuroimmunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2377-12-95","article-title":"TH1\/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab","volume":"12","author":"C Oreja-Guevara","year":"2012","journal-title":"BMC Neurol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1212\/01.wnl.0000343854.80344.69","article-title":"Neurologic immune reconstitution inflammatory syndrome in HIV\/AIDS: outcome and epidemiology","volume":"72","author":"JA McCombe","year":"2009","journal-title":"Neurology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0052208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T06:41:33Z","timestamp":1562481693000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0052208"}},"subtitle":[],"editor":[{"given":"Francesco","family":"Dieli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,20]]},"references-count":54,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0052208","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,20]]}}}